Researchers Halt Trial of Promising Sickle Cell Treatment
Two patients in a gene therapy study developed cancer years after treatment. It is not clear whether the therapy was responsible.
Source: NYT Health - Category: Consumer Health News Authors: Gina Kolata Tags: Sickle Cell Anemia Leukemia Bone Marrow Genetic Engineering Clinical Trials Bluebird Bio Inc Williams, David II DNA (Deoxyribonucleic Acid) National Heart, Lung and Blood Institute Busulfan Drugs (Pharmaceuticals) Source Type: news
More News: Anemia | Cancer | Cancer & Oncology | Cardiology | Clinical Trials | Gene Therapy | Genetics | Health | Heart | Leukemia | Sickle Cell Anemia | Study